title: Progress in the management of paraneoplastic neurological disorders.
abstract: Paraneoplastic neurological disorders (PNDs) are a rare and diverse group of neurological conditions that can involve any part of the nervous system. Diagnosis is facilitated by finding well-recognized autoantibodies directed against neural antigens in the sera and the cerebrospinal fluid. Identifying and eliminating the underlying malignancy is the mainstay of treatment. Immunomodulatory treatment is gaining more acceptance especially, where a malignancy could not be identified, oncology treatment is completed, or along with cancer treatment. Literature review shows only a handful of systematic prospective case series. Multicenter, prospective controlled clinical trials are needed for future therapeutic advances.
authors.affiliation: Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
authors.forename: Hamid
authors.initials: H
authors.lastname: Sadeghian
authors.forename: Steven
authors.initials: S
authors.lastname: Vernino